#AANAM – Soliris Lessens gMG Flares and Crises, Real-world US Study Finds

#AANAM – Soliris Lessens gMG Flares and Crises, Real-world US Study Finds

292600

#AANAM – Soliris Lessens gMG Flares and Crises, Real-world US Study Finds

Editor’s note: The Myasthenia Gravis News Today team is providing in-depth coverage of the 2021 Virtual AAN Annual Meeting, April 17–22. Go here to read the latest stories from the conference Soliris (eculizumab), a treatment for people with generalized myasthenia gravis (gMG) who fail to respond to other therapies, reduced exacerbations, MG crises, a hospitalization’s length, and the need for rescue therapy, according to data from a real-world U.S. study. Its findings also showed that…

You must be logged in to read/download the full post.